Recruiting Tardive Dyskinesia Studies in Philadelphia
About Tardive Dyskinesia Clinical Trials in Philadelphia
Tardive dyskinesia is a neurological disorder characterized by involuntary, repetitive movements, especially of the face and tongue, caused by long-term use of certain psychiatric medications. It can be socially disabling and persistent. Treatment includes VMAT2 inhibitors (valbenazine, deutetrabenazine).
There are currently 3 tardive dyskinesia clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 2,030 participants. Research is being sponsored by University of Pennsylvania, Uma Borate. Clinical trial participation is free and participants receive study-related medical care at no cost.
Tardive Dyskinesia Clinical Trials in Philadelphia — FAQ
Are there tardive dyskinesia clinical trials in Philadelphia?
Yes, there are 3 tardive dyskinesia clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Philadelphia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.
Are clinical trials in Philadelphia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.
What tardive dyskinesia treatments are being tested?
The 3 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for tardive dyskinesia.
Data updated October 16, 2026 from ClinicalTrials.gov